Entity type
Company
Filer Snapshot
CS Diagnostics Pharma GmbH
CIK 0002107192. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
1
Latest filing
04 Feb 2026
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for CSDX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
CSDX
31 Dec 2025
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
3 filed on 04 Feb 2026 for CIK 0002107192.
- Business address
- Mueller Zu Bruck Str. 12, Bruckmuehl, 83052
- Incorporated in
- Germany
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
1 identity field
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Filer intelligence
What SEC filings say about CS Diagnostics Pharma GmbH
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for CSDX.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
CSDX
31 Dec 2025 ยท 10% owner
Latest update
What changed recently for CS Diagnostics Pharma GmbH
Latest ownership report period: 31 Dec 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
04 Feb 2026
Page type
Ownership filings
Latest period
31 Dec 2025
Ownership context was refreshed from SEC Forms 3/4/5 filed on 04 Feb 2026.
Benchmark Context
Benchmark context for this company
CS Diagnostics Pharma GmbH has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest ownership report period: 31 Dec 2025. That gives you a fresh baseline before you compare this company with peers.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0002107192 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
1
First seen
04 Feb 2026
Latest filing
04 Feb 2026
Entity
Company
Observed form types
3
CIK-linked evidence first
Latest Filings
Showing the latest 1 of 1 SEC filings for CS Diagnostics Pharma GmbH.
3
File 000-29611
PRIMARY DOCUMENT
- Filing date
- 04 Feb 2026
- Reporting date
- 31 Dec 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing